About Aktis Oncology
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.
Leadership at Aktis Oncology
The team at the top of the org chart.
Matthew Roden
President & CEO
71 reports
Paul L. Feldman
Chief Scientific Officer
40 reports
Shulamit Ron-Bigger
COO
16 reports
Karen Mccarthy
VP & Head of Finance
5 reports
Akos Czibere M.D.
Chief Medical Officer
3 reports
Mary Burt
Executive Assistant
Carlos Rodriguez
Executive Director, Corporate Development
Pankaj Bhargava
Interim CMO
Board
MR
Markus Reschke
Board Observer
JC
Johannes Czernin
Advisor
KH
Ken Herrmann
Chair, Scientific Advisory Board
EC
Erik Chelius
Advisor
TF
Todd Foley
Co-Founder & Chairman
JR
Jason Ruth
Board Observer